Prognostic Nutritional Index and CRP/Albumin Ratio in Predicting Acute Pancreatitis Outcomes
Abstract
Objectives: Acute pancreatitis (AP) remains a challenging condition with variable clinical outcomes. This study investigated the prognostic value of the C-reactive protein (CRP)/albumin ratio and the Prognostic Nutritional Index (PNI) in predicting disease severity and intensive care unit (ICU) admission in patients with AP.
Materials and Methods: This retrospective study, approved by the Ethics Committee of Ankara Etlik City Hospital (28/02/2024, AEŞH-BADEK-2024-177), included 444 adults diagnosed with acute pancreatitis in the Internal Medicine Department of Ankara Etlik City Hospital. Disease severity was classified according to the Revised Atlanta criteria, and the CRP/albumin ratio and Prognostic Nutritional Index (PNI) were calculated from admission data. Receiver operating characteristic (ROC) analysis was performed to evaluate their predictive performance.
Results: Among 444 patients, 340 (76.6%) had mild and 104 (23.4%) moderate-to-severe acute pancreatitis. The moderate-to-severe group had significantly higher CRP/albumin ratios (p < 0.001) and lower PNI scores (p < 0.001). ICU patients likewise showed elevated CRP/albumin ratios (p < 0.001) and reduced PNI (p < 0.001). ROC analysis showed that the CRP/albumin ratio (AUC = 0.698) and PNI (AUC = 0.806) predicted disease severity, with optimal cut-offs of 13.43 and 47.2, respectively. For ICU admission, PNI showed superior predictive power (AUC = 0.904) to the CRP/albumin ratio (AUC = 0.705).
Conclusion: The CRP/albumin ratio and PNI are simple, cost-effective biomarkers for early risk stratification in acute pancreatitis. Both showed strong predictive value for disease severity and ICU need, with PNI demonstrating superior accuracy. These indices may support clinical decision-making, particularly in resource-limited settings.
Keywords
Acute pancreatitis, CRP/albumin ratio, Prognostic Nutritional Index, Revised Atlanta Classification, intensive care unit
Supporting Institution
None
Ethical Statement
The authors declare that the present study was conducted in accordance with the principles of the Declaration of Helsinki and the “Regulations on Drug Research, Ministry of Health, Government of Turkey, January 29, 1993’’, and approved by the Ethics Committee of the Ankara Etlik City Hospital with date and number: 28/02/2024, AEŞH-BADEK-2024-177.
Thanks
None
References
- Tenner S, Vege SS, Sheth SG, et al. American College of Gastroenterology Guidelines: Management of Acute Pancreatitis. Am J Gastroenterol. 2024;119:419–437.
- Roberts SE, Morrison-Rees S, John A, et al. The incidence and aetiology of acute pancreatitis across Europe. Pancreatology. 2017;17:155–165.
- Mederos MA, Reber HA, Girgis MD. Acute Pancreatitis: A Review. JAMA. 2021;325:382–390.
- Trikudanathan G, Yazici C, Phillips AE, et al. Diagnosis and Management of Acute Pancreatitis. Gastroenterology. 2024;167:673–688.
- Yildirim T, Kiris T, Avci E, et al. Increased Serum CRP-Albumin Ratio Is Independently Associated With Severity of Carotid Artery Stenosis. Angiology. 2020;71:740–746.
- Aydın A, Kaçmaz O. CRP/albumin ratio in predicting 1-year mortality in elderly patients undergoing hip fracture surgery. Eur Rev Med Pharmacol Sci. 2023;27:8438–8446.
- Wang R, He M, Ou X, et al. CRP Albumin ratio is positively associated with poor outcome in patients with traumatic brain injury. Clin Neurol Neurosurg. 2020;195:106051.
- Senjo H, Onozawa M, Hidaka D, et al. High CRP-albumin ratio predicts poor prognosis in transplant ineligible elderly patients with newly diagnosed acute myeloid leukemia. Sci Rep. 2022;12:8885.
- Tarar MY, Khalid A, Choo XY, et al. Use of the C-Reactive Protein (CRP)/ Albumin Ratio as a Severity Tool in Acute Pancreatitis: Systematic Review. Cureus. 2022;14: e29243.
- Mariadi IK, Somayana G, Shalim CP, et al. Prognostic value of C-reactive protein-to-albumin ratio in acute pancreatitis: a systematic review and meta-analysis. F1000Res.2023;22:12:748.